ENDEFR
Home › Sweden › ADDvance Pharma in Scandinavia AB

ADDvance Pharma in Scandinavia AB

Aktiebolag (AB) · Helsingborg, Sweden · LEI 636700RGLGM04GECZD83
LEI active

Summary

ADDvance Pharma in Scandinavia AB is registered in Sweden and entered in the “Companies Register (Bolagsverket)” under number 556641-5500. Its legal form is Aktiebolag (AB) – limited company (Sweden). According to GLEIF, its ultimate parent is Bluegreen Holding AB (Sweden), which is also its direct parent. That group has 1 subsidiary with LEIs in 1 country, 1 of them in Sweden. The LEI was first issued on 16 Dec 2022 and the record was last updated on 20 Oct 2025; the next renewal is due by 16 Dec 2026.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formAktiebolag (AB)
limited company (Sweden)
RegisterCompanies Register (Bolagsverket) · Register website
Registration number556641-5500
Registration authoritySwedish Companies Registration Office
JurisdictionSweden
Registered addressDrottninggatan 13, 252 21 Helsingborg, Sweden
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)10 Mar 2003
LEI636700RGLGM04GECZD83
LEI statusactive
LEI first issued16 Dec 2022
LEI record last updated20 Oct 2025
Next LEI renewal16 Dec 2026
Corroboration of the LEI recordfully corroborated

Group membership

Bluegreen Holding AB Sweden ultimate parent
ADDvance Pharma in Scandinavia AB this entity

Relationship to the parent

Direct parentUltimate parent
ParentBluegreen Holding ABBluegreen Holding AB
Accounting period31 Dec 2023 to 30 Dec 202431 Dec 2023 to 30 Dec 2024
Evidenceconsolidated accountsconsolidated accounts
Corroborationfully corroboratedfully corroborated
Relationship start16 Dec 202216 Dec 2022
Recorded at GLEIF since16 Dec 202216 Dec 2022
Last updated20 Oct 202520 Oct 2025
Record statuscurrentcurrent